AU3650800A - Bacterial fimbrial system for presentation of heterologous peptide sequences - Google Patents
Bacterial fimbrial system for presentation of heterologous peptide sequencesInfo
- Publication number
- AU3650800A AU3650800A AU36508/00A AU3650800A AU3650800A AU 3650800 A AU3650800 A AU 3650800A AU 36508/00 A AU36508/00 A AU 36508/00A AU 3650800 A AU3650800 A AU 3650800A AU 3650800 A AU3650800 A AU 3650800A
- Authority
- AU
- Australia
- Prior art keywords
- presentation
- peptide sequences
- heterologous peptide
- bacterial fimbrial
- bacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000001580 bacterial effect Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12788899P | 1999-04-05 | 1999-04-05 | |
US60127888 | 1999-04-05 | ||
PCT/CA2000/000356 WO2000060102A2 (en) | 1999-04-05 | 2000-04-05 | Bacterial fimbrial system for presentation of heterologous peptide sequences |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3650800A true AU3650800A (en) | 2000-10-23 |
Family
ID=22432481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU36508/00A Abandoned AU3650800A (en) | 1999-04-05 | 2000-04-05 | Bacterial fimbrial system for presentation of heterologous peptide sequences |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU3650800A (en) |
CA (1) | CA2367210A1 (en) |
WO (1) | WO2000060102A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011014693A2 (en) * | 2009-07-29 | 2011-02-03 | Whitehead Institute For Biomedical Research | Bacteriophages expressing amyloid peptides and uses thereof |
WO2024050627A1 (en) * | 2022-09-07 | 2024-03-14 | Bourgault Steve | Csga-derived nanostructures and uses thereof for antigen delivery |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991018092A1 (en) * | 1990-05-23 | 1991-11-28 | University Of Maryland At Baltimore | Acid-tolerant salmonella typhi, double aro mutants thereof and use as an oral vaccine for typhoid fever |
-
2000
- 2000-04-05 WO PCT/CA2000/000356 patent/WO2000060102A2/en active Application Filing
- 2000-04-05 AU AU36508/00A patent/AU3650800A/en not_active Abandoned
- 2000-04-05 CA CA002367210A patent/CA2367210A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000060102A3 (en) | 2001-01-04 |
WO2000060102A2 (en) | 2000-10-12 |
CA2367210A1 (en) | 2000-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1875997A (en) | Pharmaceutical composition for immunomodulation | |
AU7445498A (en) | Dipeptide derivatives as growth hormone secretagogues | |
AU4057100A (en) | Multimedia schedule presentation system | |
AU2001238482A1 (en) | Process for making granulated n-(n-(3,3-dimethylbutyl)-l-alpha-aspartyl)-l-phenylalanine 1-methyl ester | |
AU4133701A (en) | Methods and compositions for peptide synthesis | |
AU4551199A (en) | Novel therapeutic agents for membrane transporters | |
AU1951201A (en) | Peptide antigens | |
AU7105996A (en) | Bacterial delivery system | |
AU4405800A (en) | Methods for regulating protein conformation using molecular chaperones | |
AU2002244071A1 (en) | Expression system for seed proteins | |
AU4711000A (en) | Vector-mediated delivery of integrating transposon sequences | |
AU5586900A (en) | Device for displaying multiple scenes animated by sequences of lights | |
AU3650800A (en) | Bacterial fimbrial system for presentation of heterologous peptide sequences | |
AU5154498A (en) | Peptides for gene delivery | |
AU2735897A (en) | Ribosomes as vectors for rna | |
AU6553998A (en) | Methods for inhibiting bacterial cytotoxicity | |
AU2108999A (en) | Pseudo dedicated line remote information delivery system | |
AU4352000A (en) | Clasp-2 transmembrane proteins | |
AUPQ180499A0 (en) | Beta-amyloid peptide inhibitors | |
AU2449501A (en) | Vesicle trafficking proteins | |
AU4547600A (en) | Bacterial culture | |
AU2320700A (en) | Slow growing acid-fast bacterium polypeptide | |
AU3821095A (en) | Vaccine preparation recovered from bacteria grown in iron-rich media | |
AU1291801A (en) | Salts of enalapril | |
AU2300000A (en) | Novel uses of abca-type transporters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |